Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults
Type 2 diabetes affects millions of people worldwide and significantly contributes to morbidity and mortality of those affected by it. Current guidelines recommend individualized treatment regimens following first line metformin therapy. Saxagliptin, a dipeptidyl-peptidase 4 inhibitor, provides a se...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Libertas Academica
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738378/ |